Project Grant HT9425261E352
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Tampa VA Research and Education Foundation, Inc. a $639,831 project grant under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2025, through September 29, 2029. The grant supports a randomized clinical trial focused on reducing aggression in military personnel. The research will be conducted at the foundation's facility in Temple Terrace, Florida, and represents part of the...
- Federal Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine Division received a $1.0 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2026, with an ultimate completion date of September 29, 2029. The project, titled "Immunoassay Development and Validation of HDGFL2-CE as a Monitoring and Susceptibility/Risk Biomarker in ALS,"...
- Federal Grant Award Summary The Roskamp Institute, Inc. received a $770,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026, through August 31, 2029. The grant funds research to identify immune signatures linked to military-related toxicant exposure that can serve as biomarkers for Gulf War Illness (GWI) diagnosis and therapeutic response monitoring. This three-year initiative will deliver...
- Federal Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine received a $602,841 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 15, 2026, through June 14, 2030. The award supports "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," a research initiative designed to advance early...
- Federal Grant Award Summary The University of Miami, Office of Research Administration - School of Medicine, received a $1,092,670 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded June 15, 2026, with completion targeted for June 14, 2030. The project, titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," will deliver research...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $152,500 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a completion date of July 31, 2027. This award supports advanced biomedical research focused on "Targeting TIE2 as a Novel Strategy in VEGFR Inhibitor-Resistant Angiosarcoma," with work being performed in Gainesville, Florida....
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Veterans Medical Research Foundation of San Diego a $2,074,865 Project Grant effective September 1, 2025, through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). The award funds research to develop machine learning algorithms that utilize pre-intervention supraspinal functional connectivity imaging data to predict patient responsiveness to repetitive transcranial magnetic stimulation...
- Federal Grant Award Summary 149 Bio LLC received a $5.1M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2029. The award supports the development of a myeloid-targeted novel therapeutic intervention for glomerular diseases. This research initiative will be conducted at the awardee's facility in Miami, FL and aims to advance biomedical solutions relevant to military health...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $1,166,594 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with completion targeted for August 31, 2029. The research project, titled "Early Cardiac Biomarkers of Inflammation and Remodeling in Duchenne Muscular Dystrophy (DMD)," focuses on identifying and characterizing early cardiac...
- Federal Grant Award Summary Florida State University's Sponsored Research Administration Division received a $1.2 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded November 1, 2026, with a completion date of October 31, 2030. The project, titled "Targeting Exertional Dyspnea in Deployed Veterans Using Time-Efficient, High-Resistance Inspiratory Muscle Training," addresses respiratory dysfunction...
The Defense Health Agency (DHA) awarded $769,999 to the South Florida Veterans Affairs Foundation For Research And Education, Inc. under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2026 through July 31, 2029. The project investigates sphingolipids and eicosanoids derived from plasma and tear fluid as disease-relevant biomarkers in Gulf War Illness. This three-year research initiative will be conducted at the awardee's facility in Miami, Florida, and contributes to the DHA's broader portfolio of biomedical research addressing Service Member health and conditions affecting the military population. The funded research aligns with the Military Medical Research and Development program's mission to advance medical solutions for Service Members through innovative investigation. The South Florida Veterans Affairs Foundation For Research And Education, a non-profit organization with established experience in federal medical research funding and partnership coordination, will lead this investigator-initiated project to identify and characterize lipid-based biomarkers that may improve understanding and diagnosis of Gulf War Illness, a chronic multi-symptom illness affecting deployed veterans. The research represents a typical project grant within this program, which predominantly funds Project Grants averaging three to four years in duration and ranging from $100,000 to $20 million.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $770.0k | 7/15/26 |